Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Combination Therapy vs Premixed Insulin in Newly-diagnosed Type 2 Diabetes
NCT03700801Phase 4Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs), saxagliptin, dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Southern Medical University Zhujiang Hospital. Started Oct 2018; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)saxagliptindapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03700801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03700801.